Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
13 December, 2017 16:42 IST
Cipla in partnership with MMV launches quality-assured RAS
Source: IRIS | 26 Jul, 2017, 10.19AM
Comments  |  Post Comment

Cipla, a global pharmaceutical company, and the product development partnership Medicines for Malaria Venture (MMV) announced the launch of 100 mg Artesunate Rectocaps/Rectal Artesunate Suppositories (RAS), a life-saving, pre-referral intervention for the management of severe malaria in young children.

Initially developed by the World Health Organization's (WHO) Tropical Diseases Research programme, RAS 100 mg manufactured by Cipla was recently added to the Global Fund Expert Review Panel's list of quality-assured medicines, while the process of WHO prequalification of this medicine moves through its final stages. This authorization makes it the first quality-assured RAS product.

Umang Vohra, MD and Global CEO, Cipla, said, ''Cipla is committed to providing access to affordable medicines. Our endeavour is to make RAS 100 mg available in rural areas in Africa and to national community health programmes, notably with the support of international donors that have already pledged to procure Rectal Artesunate.''

Shares of the company gained Rs 0.55, or 0.1%, to trade at Rs 565.05. The total volume of shares traded was 13,421 at the BSE (10.08 a.m., Wednesday).





Cipla Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Bharti Airtel sells 20% stake in DTH arm to Warburg Pincus - 13-Dec-2017 11:24
Seamec enters into contract with Dolphin Offshore for 'SEAMEC III' - 13-Dec-2017 11:13
Asian Paints acquires 100% stake in Reno for Rs 1.59 bn - 13-Dec-2017 10:18
Punj Lloyd wins orders worth Rs 14.53 bn from GAIL, NHAI - 13-Dec-2017 10:14
JB Chemicals receives USFDA nod for Atenolol tablets - 13-Dec-2017 10:08
Kalpataru Power bags new orders worth Rs 8.75 bn - 13-Dec-2017 10:05
Ramco Systems wins order from SUEZ Middle East Water Services - 12-Dec-2017 15:22
BHEL commissions coal-fired power project in Indonesia - 12-Dec-2017 15:14
Alembic Pharma gets USFDA's nod for Darifenacin tablets - 12-Dec-2017 11:58
Infosys features as leader in software testing in NelsonHall report - 12-Dec-2017 10:03
Fiberweb India bags export orders worth Rs 152 mn - 12-Dec-2017 10:00
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer